Instil Bio, Inc.

NASDAQ (USD): Instil Bio, Inc. (TIL)

Last Price

30.84

Today's Change

+2.40 (8.43%)

Day's Change

28.35 - 32.509

Trading Volume

198,186

Overview

Market Cap

200 Million

Shares Outstanding

6 Million

Avg Volume

280,781

Avg Price (50 Days)

41.34

Avg Price (200 Days)

18.84

PE Ratio

-1.68

EPS

-18.39

Earnings Announcement

11-Nov-2024

Previous Close

28.44

Open

29.05

Day's Range

28.35 - 32.5184

Year Range

6.08 - 92.0

Trading Volume

198,186

Price Change Highlight

1 Day Change

8.44%

5 Day Change

7.05%

1 Month Change

-20.23%

3 Month Change

185.56%

6 Month Change

174.62%

Ytd Change

296.91%

1 Year Change

340.70%

3 Year Change

-92.83%

5 Year Change

-94.17%

10 Year Change

-94.17%

Max Change

-94.17%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small cell lung cancer, head and neck squamous cell carcinoma, and cervical cancer; and ITIL-306 to recognize folate receptor alpha (FOLR1) with indications, including gynecological, non-small cell lung cancer, renal caner, and others. The company was incorporated in 2018 and is headquartered in Dallas, Texas.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment